Getting to grips with gefitinib

Author： Renee Bailey L.   Janas M.  

Publisher： Elsevier

ISSN： 1470-2045

Source： Lancet Oncology, Vol.4, Iss.12, 2003-12, pp. : 719-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resistance to gefitinib

By Uramoto Hidetaka   Sugio Kenji   Oyama Tsunehiro   Sugaya Masakazu   Hanagiri Takeshi   Yasumoto Kosei  

International Journal of Clinical Oncology, Vol. 11, Iss. 6, 2006-12 ,pp. : 487-491

Springer Publishing Company

Access to resources Recommend Favorite

Acute gefitinib-induced pneumonitis

By Ohyanagi Fumiyoshi   Ando Yuichi   Nagashima Fumio   Narabayashi Masaru   Sasaki Yasutsuna  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 406-409

Springer Publishing Company

Access to resources Recommend Favorite

Gefitinib concentrations in human glioblastoma tissue

By Hofer Silvia   Frei Karl  

Journal of Neuro-Oncology, Vol. 82, Iss. 2, 2007-04 ,pp. : 175-176

Springer Publishing Company

Access to resources Recommend Favorite

Gefitinib: re-emerging from the shadows

By Martin Petra   Owen Scott P   Leighl Natasha B  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 423-437

Future Medicine

Access to resources Recommend Favorite

Three Case Reports of Hand-Foot Syndrome with Gefitinib

By Razis Evangelia   Karina Maria   Karanastassi Sofia   Fountzilas George  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 514-516

Informa Healthcare

Access to resources Recommend Favorite